Conmed Corp at Morgan Stanley Global Healthcare Conference Transcript
All right, thanks, everyone, for joining us today. I'm Drew Ranieri, a member of the medtech team here. It's my pleasure to have Curt Hartman and Todd Garner, the CEO and CFO of CONMED. Before we kind of jump into Q&A, just our quick disclaimer, but for important disclosures, please see Morgan Stanley Research disclosure's website. And if you have any questions, just reach out to your Morgan Stanley sales rep.
Questions & Answers
But again, pleasure Curt and Todd to have you with us today. And we kind of started some of these conversations really kind of on the macro standpoint. And just as we've kind of heard through the past couple of days and even last week, it sounds like from a procedure volume perspective that things have slowed down in June, July and then improved in August and even into September. But we would kind of love to hear your views on that from a sports medicines perspective
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
